Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers

KRAS, NRAS and BRAF are kinases involved in the RAS-RAF-MAPK signaling pathway and also potential tumor-driven genes. Patients with KRAS/NRAS/BRAF mutations are resistant to anti-EGFR monoclonal antibody therapy. The main purpose of this study is to investigate the mutation status and distribution o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Yang, Qiwei, Huo, Sibo, Sui, Yujie, Du, Zhenwu, Zhao, Haiyue, Liu, Yu, Li, Wei, Wan, Xin, Liu, Tongjun, Zhang, Guizhen
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6212577/
https://ncbi.nlm.nih.gov/pubmed/30416987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00487
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars